Published in Arzneimittelforschung on January 01, 1978
Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol (2006) 1.34
Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol (1992) 1.21
Modest opioid withdrawal suppression efficacy of oral tramadol in humans. Psychopharmacology (Berl) (2007) 1.06
Effects of the central analgesic tramadol and its main metabolite, O-desmethyltramadol, on rat locus coeruleus neurones. Br J Pharmacol (1993) 0.99
Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy. Br J Pharmacol (2000) 0.96
Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl) (2010) 0.90
Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug Alcohol Depend (2010) 0.87
Worldwide research productivity on tramadol: a bibliometric analysis. Springerplus (2016) 0.84
Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs (1996) 0.77
Potential for tramadol abuse by patients visiting pharmacies in northern iran. Subst Abuse (2011) 0.75
Time dependent antinociceptive effects of morphine and tramadol in the hot plate test: using different methods of drug administration in female rats. Iran J Pharm Res (2015) 0.75
Tramadol analgesia. Synergy in research and therapy. Drugs (1994) 0.75
Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther (1992) 3.58
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther (1993) 1.71
Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung (1988) 1.67
Antinociceptive effect of intrathecally administered P2-purinoceptor antagonists in rats. Brain Res (1994) 1.07
Comparative teratological investigation of compounds structurally and pharmacologically related to thalidomide. Arzneimittelforschung (1981) 0.98
Bioavailability of enteral tramadol formulations. 1st communication: capsules. Arzneimittelforschung (1986) 0.97
Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy. Br J Pharmacol (2000) 0.96
Effect of the opioid analgesic tramadol on inactivation of norepinephrine and serotonin. Biochem Pharmacol (1982) 0.93
Analgesic effects of 1',1' dimethylheptyl-delta8-THC-11-oic acid (CT3) in mice. Life Sci (1998) 0.88
A quantitative method for measuring antipsoriatic activity of drugs by the mouse tail test. Skin Pharmacol (1992) 0.86
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories. Arzneimittelforschung (1998) 0.84
Absence of emetic effects of morphine and loperamide in Suncus murinus. Eur J Pharmacol (1994) 0.80
Galanin receptor antagonists attenuate spinal antinociceptive effects of DAMGO, tramadol and non-opioid drugs in rats. Brain Res (1996) 0.79
[Bioavailability of penicillin V in aqueous dosage forms]. Arzneimittelforschung (1984) 0.79
[General pharmacological studies on tramadol, a potent analgetic agent (author's transl)]. Arzneimittelforschung (1978) 0.78
Protection by recombinant human superoxide dismutase in lethal rat endotoxemia. Prog Clin Biol Res (1989) 0.76
Effects of recombinant human superoxide dismutase on increased lung vascular permeability and respiratory disorder in endotoxemic rats. Circ Shock (1990) 0.75
Comparison of the protective effects by human and bovine superoxide dismutase against ischemia- and reperfusion-induced impairment of kidney function in anesthetized rats. Free Radic Biol Med (1987) 0.75
Spinal antinociception by morphine in rats is antagonised by galanin receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.75
[Clinical photography in dental practice. I]. Quintessenz (1972) 0.75
[Professional stress for nurses. I]. Krankenpflege (Frankf) (1992) 0.75
[Professional stress for the nursing personnel. II]. Krankenpflege (Frankf) (1992) 0.75
[Synthesis of the isomeric 3-(pyridyl)- and 3-(piperidyl)-5-hydroxyindoles (author's transl)]. Arch Pharm (Weinheim) (1975) 0.75
Additional myocardial salvage by coadministration of the epoprostenol analog taprostene to recombinant single-chain urokinase-type plasminogen activator in a canine coronary thrombosis model. Arzneimittelforschung (1989) 0.75
[Clinical photography in dental practice. 2]. Quintessenz (1972) 0.75
Analgesic and antitussive properties of EM 405. Agents Actions (1991) 0.75
[Pharmacological investigations with the combination sulfamoxole/trimethoprim, a new broadspectrum chemotherapeutic agent (author's transl)]. Arzneimittelforschung (1976) 0.75
Clinical photography in the dental practice. II. Quintessence Int Dent Dig (1972) 0.75
Selective fibrinolytic activity of recombinant non-glycosylated human pro-urokinase (single-chain urokinase-type plasminogen activator) from bacteria. Arzneimittelforschung (1987) 0.75
EM 405: a new compound with analgesic and anti-inflammatory properties and no gastrointestinal side-effects. Agents Actions (1992) 0.75
Experimental animal investigations with rifampicin on the question of its influence on the vestibular system and its period of retention in the perilymph of the inner ear. Antibiot Chemother (1970) 0.75
[Stresses on nursing personnel. 2]. Pflege (1993) 0.75
Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model. Arzneimittelforschung (1988) 0.75
Clinical photography in the dental practice. Quintessence Int Dent Dig (1972) 0.75
[Stresses for the nursing personnel. 1. Partial results of a qualitative study with nursing personnel (supported by the Agnes Karll Foundation for Nursing Research]. Pflege (1992) 0.75
[3-(Pyridylmethyl)- and 3-(piperidylmethyl)-5-hydroxyindoles (author's transl)]. Arch Pharm (Weinheim) (1975) 0.75
[Old problems and new aspects in research on analgesia (author's transl)]. Arzneimittelforschung (1978) 0.75
[Pharmacologic and toxicologic studies on benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate--a new spasmolytic]. Arzneimittelforschung (1966) 0.75
Immunosuppressive activity of cyclic imides in laboratory animals. Int J Lepr Other Mycobact Dis (1972) 0.75
Chemical, enzymological and pharmacological equivalence of urokinases isolated from genetically transformed bacteria and human urine. Arzneimittelforschung (1985) 0.75
[Clinical photography in dental practice. (IV)]. Quintessenz (1972) 0.75
Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis. Thromb Res (1989) 0.75
[On separation of isomeres, structural elucidation and pharmacological characterization of 1-(m-methoxyphenyl)-2-(dimethylaminomethyl)-cyclohexan-1-ol (author's transl)]. Arzneimittelforschung (1978) 0.75
[Studies on chemical structure and analgetic activity of phenyl substituted aminomethylcyclohexanoles (author's transl)]. Arzneimittelforschung (1978) 0.75
[Studies on the CNS activity profile of thalidomide analogs (author's transl)]. Arzneimittelforschung (1982) 0.75
Clinical photography in the dental practice. IV. Quintessence Int Dent Dig (1973) 0.75
[Clinical photography in dental practice. (3)]. Quintessenz (1972) 0.75
Equieffective protection by human and bovine SOD against renal reperfusion damage in rats. Basic Life Sci (1988) 0.75
Clinical photography in the dental practice. (I). Quintessence Int Dent Dig (1972) 0.75
Diazabicyclononanones, a potent class of kappa opioid analgesics. Farmaco (2002) 0.75